Search

Author/Creator Raiter, Yaron

1. Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study. Issue 1 (4th September 2018)

Authors:
Blevins, Thomas C.; Barve, Abhijit; Sun, Bin; Raiter, Yaron; Aubonnet, Patrick; Muniz, Rafael; Athalye, Sandeep; Ankersen, Michael
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 1(2019)
Page Start:
129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study. Issue 3 (4th December 2019)

Authors:
Blevins, Thomas C.; Barve, Abhijit; Raiter, Yaron; Aubonnet, Patrick; Athalye, Sandeep; Sun, Bin; Muniz, Rafael
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 3(2020)
Page Start:
365
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar MYL‐1601D with US and European insulin aspart in healthy volunteers: A randomized, double‐blind, crossover, euglycaemic glucose clamp study. Issue 12 (25th August 2021)

Authors:
Hövelmann, Ulrike; Raiter, Yaron; Chullikana, Anoop; Liu, Mark; Donnelly, Charles; Lawrence, Tracey; Sengupta, Nilanjan; CL, Gopu; Ranganna, Gopinath; Barve, Abhijit
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 23:Issue 12(2021)
Page Start:
2670
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search